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Background/aim: Nosocomial infections occur worldwide and affect both developed and resource-poor countries. The aim of this
paper was to determine the prevalence and risk factors for nosocomial infections in one Serbian hospital.
Materials and methods: Three-point prevalence surveys were conducted in the Clinical Center of Kragujevac (1240 beds). The standard
definitions for nosocomial infections of the Centers for Diseases Control and Prevention were used. The authors conducted surveys
according to the same protocol.
Results: The prevalence of infected patients and the overall prevalence of nosocomial infections was 6.2% and 7.1% in 2003, 4.6% and
4.6% in 2005, and 7.6% and 8.7% in 2009, respectively. In all three studies, the risk factors for nosocomial infections were older age,
intravascular catheters, urinary catheters, longer hospital stays, hospitalization in an intensive care unit, and surgeries. According to the
multivariate regression analysis, a prolonged hospitalization and use of a urinary catheter were independent risk factors for nosocomial
infections in the first and second study.
Conclusion: The overall healthcare-associated infection prevalence in our hospital increased from 2003 to 2009, and this was an
incentive for a better definition of infection control priorities in high-risk departments.
Key words: Nosocomial infection, prevalence, repeated survey, university hospital, risk factors

1. Introduction
The incidence of nosocomial or healthcare-associated
infections (HAIs) is a major public health problem
worldwide (1–3). According to definitions provided by the
Centers for Disease Control and Prevention (CDC) for the
purposes of surveillance in acute care settings, an HAI is
a localized or a systemic condition that appears as a result
of an adverse reaction to the presence of an infectious
agent or its toxin (4–6). There must be no evidence that
the infection was present or incubating at the time of
admission to the acute care setting.
A prevalence study is one possible method for
surveillance of HAIs and has been accepted in many
countries, including Serbia (7). Since the World Health
Organization prevalence survey was conducted in 47
hospitals in 14 countries (8), many developed (9–13)
and less-developed countries (14–17) have started to
conduct their own prevalence studies. Although a large
and prospective incidence study is a gold standard for
HAI surveillance, it is expensive and time-consuming
and requires a large staff. Prevalence studies offer
* Correspondence: drmilenailic@yahoo.com

advantages when a HAI surveillance system has not yet
been developed, especially when financial support is also
lacking (18). The results of repeated prevalence surveys
can be compared over time and can also provide useful
information regarding the evolution of HAI trends.
Furthermore, repeated studies increase awareness among
healthcare workers and can assist the infection control
personnel in defining possible HAI problems in various
departments (19,20).
The aim of this paper was to determine the prevalence
of HAIs in a tertiary university hospital, compare the
prevalence rate over time, and study the risk factors.
2. Materials and methods
2.1. Setting
The Clinical Center of Kragujevac is a 1240-bed
tertiary-care university hospital in Kragujevac, Serbia.
There are numerous medical departments in the center
such as surgery, internal medicine, gynecology and
obstetrics, orthopedics and traumatology, urology, ENT,
ophthalmology, neurology, psychiatrics, pediatrics,
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infectious diseases, skin and venereal diseases, oncology,
nuclear medicine, physical medicine and rehabilitation,
clinical pharmacology, and an intensive care unit. Until
2000, the center did not have a ratified infection control
program. However, guidelines for rational antibiotic use
were recently suggested, as well as guidelines for prevention
of surgical site infection and hand hygiene.
2.2. Study design
Three-point prevalence surveys were carried out in
December 2003, May 2005, and June 2009. The same
method was applied in all studies. All patients staying
more than 48 h in the hospital at the time of the surveys
were included in the studies. Every patient was registered
only once. If a patient was visited twice on the same day
at the time of the study, possibly due to a transfer between
clinics, only the first treatment episode was registered.
Every study was performed in a single day in one hospital
ward, and the entire study was completed during 1 week,
as recommended in previous research (HAI was defined
according to CDC criteria (4) and subsequently translated
into Serbian) (21). We used these definitions for all three
studies. As a result, we were able to compare the results of
the surveys. All infections were categorized into 13 major
and specific infection sites. Asymptomatic bacteriuria was
not considered as an infection. Only HAIs active on the day
of the survey were taken into consideration.
Data were collected using a standardized questionnaire
based on the patients’ medical and nursing records,
microbiological and X-ray reports, and interviews with the
patients and physicians. The following clinical characteristics
were also recorded: demographic data, date of admission,
disease type and comorbidities on admission, hospital
ward and intensive care unit (ICU), interventions (the
presence of an indwelling catheter at the time of the survey;
a surgical procedure in the month preceding the survey,
or the year preceding the survey in the case of a prosthesis
implantation), their corresponding dates and duration of
stay, and the use of antimicrobials. We calculated the length
of hospitalization as the number of days from admission to

the date of surveys. The same epidemiologist and infection
control nurses conducted all surveys.
2.3. Data analysis
The prevalence of HAI was presented as the prevalence
of infected patients (with at least one infection) and the
prevalence of infection. Confidence intervals (CIs) of 95%
were calculated. The differences between infected and
noninfected patients were assessed using a chi-square or
a Fisher exact test for categorical variables and a Student
t-test for continuous variables. Univariate and multivariate
logistic regression was used to examine variables potentially
associated with HAIs. All statistical analyses were carried
out using SPSS (SPSS Inc., Version 7.5, Chicago, IL, USA).
3. Results
A total of 764 patients were examined in the first study, 866
patients in the second, and 865 patients in the third. The
prevalence of infected patients and the overall prevalence
of HAI was 6.2% and 7.1% in 2003, 4.6% and 4.6% in 2005,
and 7.6% and 8.7% in 2009, respectively (Table 1).
Table 2 shows the prevalence of infected patients
with respect to different departments in the hospital. The
highest prevalence rate was noted as occurring in urologic
surgery, followed by orthopedic surgery and the ICU in the
first and second surveys. In the third survey, the highest
prevalence was observed in the ICU (53.8%), followed by
urologic surgery (22.7%) and orthopedic surgery (19.1%).
The prevalence of HAIs according to the site of infections
is shown in Table 3. Of all HAIs detected in all studies, the
most frequent were surgical site infections (SSIs) in the first
study and urinary tract infections (UTIs) in the second and
third studies. SSI prevalence did not decrease significantly
over time, while UTIs showed increased prevalence during
the survey period.
Several risk factors associated with HAIs in the
univariate logistic regression analysis are shown in Table 4.
The mean age of the patients was 48.70 ± 23.95 years (range:
1–85) in the first study, 50.40 ± 24.63 (range: 1–91) in the
second, and 50.62 ± 23.37 (range: 1–89) in the third. Older

Table 1. The three surveys of health care-associated infections (HAIs).
Variables

Survey I

Survey II

Survey III

Survey period

December 2003

May 2005

June 2009

Number of hospitalized patients

764

866

865

Patients with at least one HAI

47

40

66

4.6 (1.4–7.8)

7.6 (5.9–9.6)

Prevalence of infected patients (95% CI*)
Overall number of HAIs (%)

54

40

75

Prevalence of HAIs (%)

7.1

4.6

8.7

95% CI: 95% confidence interval.

*
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Table 2. Prevalence (%) of patients with health care-associated infection by unit/department.

Clinical department

Survey I
(N = 764)
Patients (%)

Survey II
(N = 866)
Patients (%)

Survey III
(N = 865)
Patients (%)

Medicine internal

16 (4.1)

12 (3.2)

36 (6.2)

Surgery

15 (9.3)

10 (4.1)

11 (6.5)

Urological

5 (21.0)

6 (25.0)

5 (22.7)

General

9 (9.0)

0-

5 (4.2)

Other

1 (2.6)

4 (7.5)

1 (3.6)

Intensive care unit

2 (16.7)

11 (8.0)

7 (53.8)

Orthopedic

8 (20.0)

6 (12.0)

9 (19.1)

Obstetrics and gynecology

6 (2.2)

1 (3.1)

2 (3.4)

Total

47 (6.2)

40 (4.6)

6 (7.6)

Table 3. Prevalence of health care-associated infection (HAI) according to the site of infection.
Major site of infection

Survey I
HAI (%)

Survey II
HAI (%)

Survey III
HAI (%)

P

Urinary tract

10 (1.3)

18(2.1)

25 (2.9)

0.021

Bloodstream

3 (0.4)

1 (0.1)

3 (0.3)

0.783

Pneumonia

6 (0.8)

5 (0.6)

19 (2.2)

0.069

Surgical site

18 (2.4)

7 (0.8)

13 (1.5)

0.068

Skin and soft tissue

11 (1.4)

6 (0.7)

9 (1.0)

0.345

Other

6 (0.7)

3 (0.3)

6 (0.7)

0.779

Total

54 (7.1)

40 (4.6)

75 (8.7)

0.003

Table 4. Intrinsic and extrinsic risk factors for health care-associated infection: univariate logistic regression analysis.
2003
Variables

Infected
patients N (%)

2009

OR* (95% CI)†

Infected
patients N (%)

OR (95% CI)

Infected
patients N (%)

OR (95% CI)

1.89 (0.99–3.55)

33 (11.6)

2.23 (1.37–3.63)

37 (9.2)

0.78 (0.48–1.26)

Age ≥65 years

23 (9.2)

2.20 (1.20–4.05)

21 (6.4)

Sex (Male)

22 (6.6)

0.80 (0.44–1.44)

21 (5.4)

Hospital unit

2.23 (1.23–4.04)

0.73 (0.39–1.39)
0.98 (0.51–1.87)

1.58 (0.97–2.57)

Internal medicine

21 (4.4)

24 (4.7)

36 (6.5)

Surgery

26 (9.2)

16 (4.6)

30 (9.5)

Hospitalization in an ICU
Hospital stay (days): ≥8

‡

7 (21.9)

3.71 (1.69–8.17)

11 (8.0)

2.09 (1.02–4.29)

18 (27.3)

1.51 (1.02–2.24)

35 (10.8)

3.49 (1.84–6.64)

31 (7.7)

4.24 (1.99–9.01)

53 (12.8)

4.94 (2.71–9.00)

19 (14.8)

3.43 (1.84–6.38)

12 (7.2)

1.86 (0.92–3.73)

23 (15.6)

2.99 (1.77–5.05)

Intravascular devices

35 (10,0)

3.74 (1.91–7.33)

25 (8.1)

3.21 (1.67–6.19)

47 (10.6)

2.35 (1.39–3.99)

Urinary catheter

19 (18.8)

5.30 (2.82–9.96)

17 (10.6)

2.41 (1.47–3.96)

32 (18.9)

5.29 (3.18–8.79)

Antibiotic use

44 (11.3)

15.80 (4.86–51.33)

39 (14.6)

101.67 (13.89–744.27)

55 (16.6)

10.32 (5.34–19.42)

Surgical interventions

*

2005

§

OR: odds ratio, value according to univariate logistic regression analysis; †95% CI: 95% confidence interval; ‡ICU: intensive care unit;
underwent previous surgical procedure (in the 30 days before onset of infection or the 30 days before the survey day).

§
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age, intravascular catheters, urinary catheters, longer
hospital stay from admission to the date of the surveys,
hospitalization in an ICU, and surgical interventions
and antibiotic use were associated with HAIs in all three
studies.
According to multivariate regression analysis, a
hospitalization equal to or longer than 8 days from
admission to the date of the surveys and the use of urinary
catheters were independent risk factors for HAI in the first
and the second study. In addition to these factors, older age
was an independent risk factor in the third study (Table 5).
In total, microbiological examination was conducted in
71.4% cases of HAI, 87.0% (47/54) in the first study, 62.5%
(25/40) in the second, and 73.3% (55/75) in the third. The
most frequently isolated bacteria are shown in the Figure.
The increase of gram-negative rods is noted. The number
of patients receiving treatment with at least one antibiotic
agent on the day of the study was 330 (45.8% of the total)
in the first study, 268 (30.9% of the total) in the second,
and 324 (37.5% of the total) in the third.
4. Discussion
Prevalence surveys of HAIs have been widely used
both in national and local settings. Over time, more
comprehensive data have been obtained from repeated
prevalence surveys. However, when prevalence surveys are
conducted, they should be performed with standardized
methodology (18). Despite the long period that elapsed
between our studies, we assume that the prevalence rates
can be clearly compared because the same infection control
staff conducted all studies using the same definitions of
HAI, and the tests were carried out in the same laboratory
for microbiological confirmation of infections.
The overall prevalence rates of HAI in our study were
7.1%, 4.6%, and 8.7% in the first, second, and third study,

respectively. These rates were lower than the rates of
studies carried out in university hospitals in neighboring
countries (15,22) and in other developing countries (14,23)
but higher than the rates in most developed countries.
Studies conducted in western European countries showed
that the prevalence of HAI in hospitals was between 3.5%
and 8.5% (9–13,24). Ten annual prevalence surveys were
conducted in a 900-bed tertiary-care hospital in the USA;
however, the prevalence of patients with HAIs showed no
significant increase during the 10-year period, although
the rate of bloodstream infection significantly increased
(25).
Although surgical interventions are still an important
risk factor for HAI (26), our study shows that the
prevalence of SSIs nonsignificantly decreased over time,
while the prevalence of UTIs significantly increased. The
national recommendation for prevention of SSI, which
includes antibiotic prophylaxis, published at the beginning
of 2005, probably influenced this decreasing trend.
Similar results were also obtained for the whole of Serbia.
Specifically, SSIs were the most common type in the first
national study conducted in 1999, making up 34% of all
HAIs, but came in second position in the second and third
national studies (accounting for 24% and 23% of all HAIs,
respectively) after UTIs (17). SSIs are the most frequent
type of infection in hospitals in developing countries (27),
while UTIs are the most frequent in developed European
countries and in the United States (28).
It is well known that improvements in the timing of initial
antibiotic administration, appropriate choice of antibiotic
agents, and short durations of antibiotic administration
are inversely related to the risk of SSI (29). Therefore,
there is an urgent need to organize the infection control
measures for UTI and pneumonia. Specific guidelines for
these infections, which are crucial at the national level and

Table 5. Risk factors for health care-associated infection: multivariate logistic regression
analysis.
Survey I
(N = 764)
Variable

Survey II
(N = 866)

Survey III
(N = 865)

P*

Age ≥65 years

NS

NS

≤0.05

Hospital stay (days): ≥8

≤0.001

≤0.05

≤0.001

Surgical interventions†

≤0.05

NS

NS

Urinary catheter

≤0.01

NS

≤0.05

Antibiotic use

≤0.01

≤0.001

≤0.001

P: probability value according to multivariate logistic regression analysis (NS: not significant;
P ≤ 0.05; P ≤ 0.01; P ≤ 0.001);
†
underwent previous surgical procedure (in the 30 days before onset of infection or the 30
days before the survey day).
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Figure. Three surveys of nosocomial infections prevalence at the Clinical Center in Kragujevac: frequency of the isolated
microbial agents.

in accordance with international guidelines, should also
be adapted in our hospital. The higher prevalence of SSIs,
noted in our study more than in some other studies (9–
13,24,25), was frequently linked to peripheral intravenous
catheters. Namely, the majority of all intravascular devices,
which were primary risk factors for HAI, were peripheral
vascular catheters. Although the inoculum amount was
small, when infusate was administered for a long period
the bacteria could proliferate and cause infections (30). In
addition, a urinary catheter was the main risk factor for
HAI in all three surveys and, according to the multivariate
logistic regression, the presence of a catheter was an
independent risk factor in the first and third surveys.
Urinary catheters are the most important risk factors for
hospital UTI. Urinary catheterization for a period longer
than 6 days increased the risk of acquiring catheter-related
UTI and, by 30 days of indwelling, infection was almost
universal (31). Accordingly, the most important preventive
strategies were restricted exposure, short residence
time, intermittent catheterization, and the use of aseptic
techniques and infection control measures during catheter
interventions.
The prevalence of HAIs in our studies was higher in
the ICU than in other wards, especially in 2009. A stay

in an ICU as one of the factors contributing to infection
during hospitalization was confirmed in many studies
(12–15,22,23). HAI prevalence in an ICU was 5 to 10 times
higher than in other hospital units. This might be due to the
characteristics of patients hospitalized in ICUs and the high
exposure rates of ICU patients to invasive procedures. The
Extended Prevalence of Infection in Intensive Care (EPIC
II) study, conducted in 2007 at 1265 ICUs in 75 countries,
showed that 51% of all patients hospitalized were infected
on the day of the study (32). A significant relationship
between the time spent in the ICU prior to the study day
and the development of infection was noted. According to
our results, patients who had been in the hospital longer
than 8 days at the time of the survey had an increased risk
of nosocomial infection. It is well known that a prolonged
hospital stay can expose patients to hospital bacteria and
increase the risk of infection. However, the HAI itself
prolonged the duration of hospitalization.
Antibiotic use is more the consequence of HAI treatment
than a risk factor for their development. Antibiotic use in
all of our three studies was higher than in a study conducted
in four European countries in which about one-third of
patients were being treated with antimicrobials at the time
of the study (11). Moreover, only a few patients with HAIs
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were without antibiotherapy. As a result, the confidence
interval for antibiotic use was substantial, especially in the
second survey. It has already been determined that Serbia
is ranked fifth out of 12 newly independent countries and
southeastern European countries in terms of overall use
of antibiotics, after Turkey, Montenegro, Tajikistan, and
Kosovo (33). We believe that further analyses of antibiotic
use and its effect on the development of resistant strains
are needed in our hospital.
According to the definitions of HAI, bacteriological
confirmation is needed for many types of infections.
However, some HAIs, such as SSIs and pneumonia, can be
diagnosed according to their clinical symptoms and signs.
For this reason, the number of bacteriologically confirmed
HAIs is always less than the total number of infections.
The episodes of HAIs documented by microbiological
results were similar to those published in other European
surveys (9,13,15). The most common isolated organisms in
our surveys were gram-negative rods, similar to those in
published results in developing countries (15,22,23).
The main limitation of our investigation is the type of
study design as a point prevalence survey. In a prevalence
study, a cross-sectional approach is used, and it is more

likely to locate and record HAIs of longer duration and
patients with more comorbidities. In addition, the quality
of data depends on the availability of information in
patient records, nursing records, and prescription records.
The availability of bacteriological results also influences
the quality and accuracy of HAI diagnosis. However,
well-documented protocol, trained data collectors, and
validation of the collected data could decrease potential
bias. In our study, one trained infection control doctor (MI)
and the same infection control nurses conducted all three
studies, which was a major advantage of our investigation.
In addition, in all studies, the same methodology and the
same definition of HAI were used.
In conclusion, the considerable burden of HAIs in our
university hospital was described. Repeated prevalence
surveys of HAIs, compared over a period of time, can lead
to the implementation of specific infection control policies.
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